Olema Pharmaceuticals inc (OLMA)
5.89
+0.32
(+5.75%)
USD |
NASDAQ |
Jan 03, 16:00
5.91
+0.02
(+0.34%)
After-Hours: 20:00
Olema Pharmaceuticals Enterprise Value: 122.72M for Jan. 3, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| PTC Therapeutics Inc | 2.861B |
| Pfizer Inc | 207.62B |
| NovaBay Pharmaceuticals Inc | 2.298M |
| Palatin Technologies Inc | 24.40M |
| iBio Inc | 12.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -34.56M |
| Total Expenses (Quarterly) | 37.62M |
| EPS Diluted (Quarterly) | -0.60 |
| Earnings Yield | -37.01% |